Biopharma Stock Updates - 12/14/20

Data Updates:

$ALXN (+29%) - AstraZeneca to Acquire Alexion, Accelerating the Company's Strategic and Financial Development

https://ir.alexion.com/news-releases/news-release-details/astrazeneca-acquire-alexion-accelerating-companys-strategic-and


$ARVN (+95%) - Arvinas Releases Interim Clinical Data Further Demonstrating the Powerful Potential of PROTAC® Protein Degraders ARV-471 and ARV-110

https://ir.arvinas.com/news-releases/news-release-details/arvinas-releases-interim-clinical-data-further-demonstrating


$ARMN (+1.6%) - Multiple VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at National Lipid Association (NLA) Scientific Sessions 2020, Including First COVID-19 Clinical Results

https://investor.amarincorp.com/news-releases/news-release-details/amarin-highlights-multiple-vascepar-icosapent-ethyl-related


$BNTX (-15%) - Provide Data from German Phase 1/2 Study of COVID-19 Vaccine Candidate BNT162b2

https://biontechse.gcs-web.com/news-releases/news-release-details/pfizer-and-biontech-provide-data-german-phase-12-study-further


$GMDA (-8.5%) - Update on Biologics License Application for Omidubicel

https://investors.gamida-cell.com/news-events/press-releases/news-release-details/gamida-cell-provides-regulatory-update-biologics


$MRNA (+0.5%) - Moderna Confirms Supply Agreement with the Ministry of Health to Supply Singapore with mRNA Vaccine Against COVID-19 (mRNA-1273)

http://investors.modernatx.com/news-releases/news-release-details/moderna-confirms-supply-agreement-ministry-health-supply


Financial Updates:

$OCUL (+7.5%) - Announces public offering

http://investors.ocutx.com/news-releases/news-release-details/ocular-therapeutixtm-announces-proposed-public-offering-common-2


$ARVN (+95%) - Announces public offering

https://ir.arvinas.com/news-releases/news-release-details/arvinas-inc-announces-proposed-offering-common-stock-0


$RCKT (-6%) - Closes public offering at $56/share

https://ir.rocketpharma.com/news-releases/news-release-details/rocket-pharmaceuticals-announces-closing-public-offering-and-1

$TGTX (+3.5%) - Proposed Public Offering of Common Stock of $200,000,000

https://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-announces-proposed-public-offering-common-2


$MIRM (-5.5%) - Commencement of Public Offering of Common Stock of $75.0 million

https://mirumpharma.gcs-web.com/news-releases/news-release-details/mirum-pharmaceuticals-announces-commencement-public-offering



0 comments